Valuation: Enovis Corporation

Market Cap 149.09Cr 130.47Cr 120.24Cr 111.45Cr 211.56Cr 14TCr 214.97Cr 1.44TCr 560.67Cr 6.98TCr 559.72Cr 547.6Cr 24TCr P/E 2026 *
213x
P/E 2027 * 26.8x
Enterprise Value 268.82Cr 235.25Cr 216.8Cr 200.95Cr 381.47Cr 26TCr 387.61Cr 2.6TCr 1.01TCr 13TCr 1.01TCr 987.38Cr 44TCr EV / Sales 2026 *
1.15x
EV / Sales 2027 * 1.04x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-1.47%
1 week+23.29%
Current month+23.29%
1 month+7.77%
3 months+13.32%
6 months-7.84%
Current year-4.20%
1 week 19.86
Extreme 19.86
26.5
1 month 19.14
Extreme 19.14
26.5
Current year 19.14
Extreme 19.14
29.89
1 year 19.14
Extreme 19.14
36.82
3 years 19.14
Extreme 19.14
66.14
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

846 0.0015%
15/06Buy

Chief Administrative Officer

1,000 0.0017%
11/06Buy

Chief Administrative Officer

1,200 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%+23.29%-22.71%-60.30% 149.09Cr
+1.54%+4.73%-15.99%+12.05% 12TCr
+0.48%+4.68%+2.93%-1.89% 1.28TCr
+1.31%+7.79%+48.48%+117.61% 872.96Cr
-4.70%-1.16%-49.44%-73.07% 406.28Cr
-4.42%+2.41%+21.94%+43.47% 277.77Cr
-4.51%-2.27%-12.01%-16.99% 188.24Cr
-2.17%+0.42%-4.12%-27.70% 164.96Cr
+1.27%+12.26%-60.54%-83.92% 142.48Cr
Average -1.36%+2.85%-10.16%-10.08% 1.77TCr
Weighted average by Cap. +1.07%-1.01%-11.42%+12.80%

Financials

2026 *2027 *
Net sales 234.47Cr 205.18Cr 189.09Cr 175.27Cr 332.71Cr 22TCr 338.08Cr 2.27TCr 881.75Cr 11TCr 880.25Cr 861.19Cr 38TCr 246.65Cr 215.85Cr 198.92Cr 184.38Cr 350.01Cr 23TCr 355.65Cr 2.39TCr 927.59Cr 12TCr 926.01Cr 905.96Cr 40TCr
Net income 29.6L 25.9L 23.87L 22.13L 42L 28Cr 42.68L 2.86Cr 1.11Cr 14Cr 1.11Cr 1.09Cr 48Cr 5.42Cr 4.74Cr 4.37Cr 4.05Cr 7.69Cr 514.59Cr 7.82Cr 52Cr 20Cr 253.96Cr 20Cr 20Cr 877.81Cr
Net Debt 119.73Cr 104.78Cr 97Cr 90Cr 169.91Cr 11TCr 172.64Cr 1.16TCr 450.28Cr 5.61TCr 449.52Cr 439.78Cr 19TCr 106.59Cr 93Cr 86Cr 80Cr 151.26Cr 10TCr 153.69Cr 1.03TCr 400.86Cr 4.99TCr 400.18Cr 391.51Cr 17TCr
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
08/26/08 $25.52 -1.47% 9,68,036
06/26/06 $25.90 +15.11% 21,55,004
02/26/02 $22.50 +12.28% 13,02,522
01/26/01 $20.04 -3.19% 15,02,881
30/26/30 $20.70 -5.99% 23,73,298
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
25.90USD
Average target price
41.90USD
Spread / Average Target
+61.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock